Disposable Syringes Market Size, Share and Growth Outlook, 2026

Disposable Syringes Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Disposable Syringes Market size is forecast to increase from $17.18 Billion in 2026 to $32.27 Billion in 2034 at a CAGR of 8.2% between 2026 and 2034.

The Disposable Syringes market report provides detailed analysis and outlook of Disposable Syringes segments including By Product Type (Conventional Syringes, Safety Syringes, Auto-Disable Syringes, Prefilled Syringes, Smart), By Application (Immunization Injections, Therapeutic Injections, Blood Collection & Diagnostics), By Material (Plastic, Glass, Biodegradable), By End User (Hospitals & Clinics, Blood Collection Centres & Diagnostic Labs, Ambulatory Surgical Centres, Home Healthcare) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Disposable Syringes Industry Overview

Expanding Demand for Safe and Efficient Drug Delivery Systems

The disposable syringes industry continues to evolve as healthcare providers increasingly prioritize infection prevention, medication safety, and efficient drug administration. Single-use syringes remain essential across hospitals, ambulatory care centers, vaccination programs, blood processing facilities, and pharmaceutical manufacturing operations. Growing adoption of biologics, injectable therapies, specialty pharmaceuticals, and automated infusion technologies is driving investments in advanced syringe manufacturing, prefillable delivery systems, and connected medication administration platforms. Manufacturers are expanding production capabilities to meet rising clinical demand while supporting regulatory compliance and patient safety objectives.

Manufacturing Investments Strengthening Global Supply Capacity

Major industry participants are expanding production infrastructure to secure long-term supply availability. Sharps Technology, Inc. entered into a five-year, $200 million product sales agreement with Nephron Pharmaceuticals while advancing its acquisition of the InjectEZ syringe manufacturing facility in West Columbia, South Carolina. The initiative is designed to increase dedicated production capacity for single-use safety syringe technologies and specialized drug delivery systems.
Gerresheimer AG also expanded its manufacturing footprint through the completion of a new 7,500-square-meter production facility and cleanroom installation in Querétaro, Mexico. The expansion significantly increases the company’s output of ready-to-fill disposable plastic and glass syringes, adding several hundred million units annually to support growing North American healthcare and pharmaceutical requirements.

Prefillable Syringe Technologies Supporting Advanced Therapeutics

The growing use of biologics and injectable therapies is accelerating investment in prefillable syringe manufacturing. BD announced a $110 million expansion project at its Columbus, Nebraska facility to strengthen production of prefillable syringe systems. The investment includes new manufacturing lines for the BD Neopak™ Glass Prefillable Syringe platform, which is specifically engineered for biologic medicines and GLP-1 therapies. Additional investments in cannula manufacturing and prefilled flush syringe production further reinforce the industry's commitment to supporting advanced drug delivery requirements and pharmaceutical innovation.

Digital Infusion Technologies Enhancing Medication Administration

Integration of digital healthcare technologies is reshaping syringe-based medication delivery. Terumo India introduced the Terufusion™ Advanced Infusion Systems portfolio, featuring smart syringe pumps, volumetric infusion pumps, and Pump Monitoring System software. These technologies enable automated medication administration, enhanced dosing accuracy, and real-time monitoring capabilities within critical care environments. Connected infusion platforms are becoming increasingly important as healthcare providers seek greater precision and safety in medication management.

Automation Modernizing Blood Processing Applications

Disposable syringe technologies are also supporting advancements in blood management and transfusion medicine. SunCoast Blood Centers became the first blood center in Florida to implement Terumo Blood and Cell Technologies’ Reveos™ Automated Blood Processing System. The platform utilizes specialized automated syringes and single-use processing sets to separate whole blood into clinical-grade components, improving efficiency and consistency within blood processing workflows. Such innovations continue to strengthen the role of disposable syringe systems in modern healthcare operations.

Disposable Syringes Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Disposable Syringes market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Becton, Dickinson and Company (BD), Cardinal Health, Inc., Terumo Corporation, B. Braun Melsungen AG, Nipro Corporation, Smiths Medical (ICU Medical, Inc.), Gerresheimer AG, Retractable Technologies, Inc., Henke-Sass, Wolf GmbH, CODAN Medizinische Geräte GmbH & Co KG. The Disposable Syringes market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Disposable Syringes industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Disposable Syringes Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Disposable Syringes companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Disposable Syringes markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Disposable Syringes Market Competitive Benchmarking and Company Analysis

Leading companies in Disposable Syringes industry include- Becton, Dickinson and Company (BD), Cardinal Health, Inc., Terumo Corporation, B. Braun Melsungen AG, Nipro Corporation, Smiths Medical (ICU Medical, Inc.), Gerresheimer AG, Retractable Technologies, Inc., Henke-Sass, Wolf GmbH, CODAN Medizinische Geräte GmbH & Co KG. The Disposable Syringes market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Disposable Syringes Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Disposable Syringes market remains one of the strongest-performing segments in the country.
The US Disposable Syringes Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Disposable Syringes market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Disposable Syringes industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Disposable Syringes markets

Canada's strong Disposable Syringes sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Disposable Syringes market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Disposable Syringes Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Disposable Syringes market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Disposable Syringes population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Disposable Syringes industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Disposable Syringes market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Disposable Syringes sales through 2034

France Disposable Syringes companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Disposable Syringes Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Disposable Syringes distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Disposable Syringes Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Disposable Syringes market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Disposable Syringes industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Disposable Syringes industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Disposable Syringes Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Disposable Syringes market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Disposable Syringes market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Disposable Syringes Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Disposable Syringes Market Segmentation

By Product Type
Conventional Syringes
Safety Syringes
Auto-Disable Syringes
Prefilled Syringes
Smart
By Application
Immunization Injections
Therapeutic Injections
Blood Collection & Diagnostics
By Material
Plastic
Glass
Biodegradable
By End User
Hospitals & Clinics
Blood Collection Centres & Diagnostic Labs
Ambulatory Surgical Centres
Home Healthcare

Top Companies in Disposable Syringes Industry

Becton, Dickinson and Company (BD)
Cardinal Health, Inc.
Terumo Corporation
B. Braun Melsungen AG
Nipro Corporation
Smiths Medical (ICU Medical, Inc.)
Gerresheimer AG
Retractable Technologies, Inc.
Henke-Sass, Wolf GmbH
CODAN Medizinische Geräte GmbH & Co KG

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025